世界の乳がん診断＆薬物技術市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3938 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、乳がん診断＆薬物技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（マンモグラフィ、生検、その他）、用途別市場規模（乳管癌、浸潤性乳管癌、小葉癌、トリプルネガティブ乳がん）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・乳がん診断＆薬物技術の市場動向 ・企業の競争状況、市場シェア ・乳がん診断＆薬物技術の種類別市場規模と予測2016-2027（マンモグラフィ、生検、その他） ・乳がん診断＆薬物技術の用途別市場規模と予測2016-2027（乳管癌、浸潤性乳管癌、小葉癌、トリプルネガティブ乳がん） ・乳がん診断＆薬物技術の北米市場規模2016-2027（アメリカ、カナダ） ・乳がん診断＆薬物技術の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・乳がん診断＆薬物技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・乳がん診断＆薬物技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・乳がん診断＆薬物技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Roche、BioMerieux、Becton Dickinson、GE Healthcare、Hologic、Philips、PerkinElmer、Quest Diagnostics） ・結論

Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.

Market Analysis and Insights: Global Breast Cancer Diagnostic and Drug Technologies Market
The global Breast Cancer Diagnostic and Drug Technologies market size is projected to reach US$ 19060 million by 2027, from US$ 16050 million in 2020, at a CAGR of 2.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast Cancer Diagnostic and Drug Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast Cancer Diagnostic and Drug Technologies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast Cancer Diagnostic and Drug Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast Cancer Diagnostic and Drug Technologies market.

Global Breast Cancer Diagnostic and Drug Technologies Scope and Market Size
Breast Cancer Diagnostic and Drug Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Diagnostic and Drug Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mammography
Biopsy
Other

Segment by Application
Ductal Carcinoma of Breast
Invasive Ductal Carcinoma
Lobular Carcinoma
Triple Negative Breast Cancer

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Roche
BioMerieux
Becton Dickinson
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mammography
1.2.3 Biopsy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Ductal Carcinoma of Breast
1.3.3 Invasive Ductal Carcinoma
1.3.4 Lobular Carcinoma
1.3.5 Triple Negative Breast Cancer
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Perspective (2016-2027)
2.2 Breast Cancer Diagnostic and Drug Technologies Growth Trends by Regions
2.2.1 Breast Cancer Diagnostic and Drug Technologies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Breast Cancer Diagnostic and Drug Technologies Historic Market Share by Regions (2016-2021)
2.2.3 Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Regions (2022-2027)
2.3 Breast Cancer Diagnostic and Drug Technologies Industry Dynamic
2.3.1 Breast Cancer Diagnostic and Drug Technologies Market Trends
2.3.2 Breast Cancer Diagnostic and Drug Technologies Market Drivers
2.3.3 Breast Cancer Diagnostic and Drug Technologies Market Challenges
2.3.4 Breast Cancer Diagnostic and Drug Technologies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Diagnostic and Drug Technologies Players by Revenue
3.1.1 Global Top Breast Cancer Diagnostic and Drug Technologies Players by Revenue (2016-2021)
3.1.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Players (2016-2021)
3.2 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Diagnostic and Drug Technologies Revenue
3.4 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio
3.4.1 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Diagnostic and Drug Technologies Revenue in 2020
3.5 Breast Cancer Diagnostic and Drug Technologies Key Players Head office and Area Served
3.6 Key Players Breast Cancer Diagnostic and Drug Technologies Product Solution and Service
3.7 Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Breast Cancer Diagnostic and Drug Technologies Breakdown Data by Type
4.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Type (2016-2021)
4.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Type (2022-2027)

5 Breast Cancer Diagnostic and Drug Technologies Breakdown Data by Application
5.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Application (2016-2021)
5.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size (2016-2027)
6.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type
6.2.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021)
6.2.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027)
6.2.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2027)
6.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application
6.3.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021)
6.3.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027)
6.3.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2027)
6.4 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country
6.4.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021)
6.4.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size (2016-2027)
7.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type
7.2.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021)
7.2.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027)
7.2.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2027)
7.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application
7.3.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021)
7.3.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027)
7.3.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2027)
7.4 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country
7.4.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021)
7.4.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size (2016-2027)
8.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type
8.2.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2027)
8.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application
8.3.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2027)
8.4 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region
8.4.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size (2016-2027)
9.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type
9.2.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021)
9.2.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027)
9.2.3 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2027)
9.3 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application
9.3.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021)
9.3.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027)
9.3.3 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2027)
9.4 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country
9.4.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021)
9.4.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size (2016-2027)
10.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type
10.2.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2027)
10.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application
10.3.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2027)
10.4 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country
10.4.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Breast Cancer Diagnostic and Drug Technologies Introduction
11.1.4 Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Breast Cancer Diagnostic and Drug Technologies Introduction
11.2.4 Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
11.2.5 Roche Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Introduction
11.3.4 BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
11.3.5 BioMerieux Recent Development
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Details
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Introduction
11.4.4 Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
11.4.5 Becton Dickinson Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Introduction
11.5.4 GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
11.5.5 GE Healthcare Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic Breast Cancer Diagnostic and Drug Technologies Introduction
11.6.4 Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
11.6.5 Hologic Recent Development
11.7 Philips
11.7.1 Philips Company Details
11.7.2 Philips Business Overview
11.7.3 Philips Breast Cancer Diagnostic and Drug Technologies Introduction
11.7.4 Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
11.7.5 Philips Recent Development
11.8 PerkinElmer
11.8.1 PerkinElmer Company Details
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Introduction
11.8.4 PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
11.8.5 PerkinElmer Recent Development
11.9 Quest Diagnostics
11.9.1 Quest Diagnostics Company Details
11.9.2 Quest Diagnostics Business Overview
11.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Introduction
11.9.4 Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
11.9.5 Quest Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mammography
Table 3. Key Players of Biopsy
Table 4. Key Players of Other
Table 5. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2016-2021)
Table 9. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2022-2027)
Table 11. Breast Cancer Diagnostic and Drug Technologies Market Trends
Table 12. Breast Cancer Diagnostic and Drug Technologies Market Drivers
Table 13. Breast Cancer Diagnostic and Drug Technologies Market Challenges
Table 14. Breast Cancer Diagnostic and Drug Technologies Market Restraints
Table 15. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Players (2016-2021)
Table 17. Global Top Breast Cancer Diagnostic and Drug Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Diagnostic and Drug Technologies as of 2020)
Table 18. Ranking of Global Top Breast Cancer Diagnostic and Drug Technologies Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Breast Cancer Diagnostic and Drug Technologies Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Breast Cancer Diagnostic and Drug Technologies Product Solution and Service
Table 22. Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2016-2021)
Table 26. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Breast Cancer Diagnostic and Drug Technologies Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Application (2016-2021)
Table 30. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Breast Cancer Diagnostic and Drug Technologies Product
Table 65. Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Breast Cancer Diagnostic and Drug Technologies Product
Table 70. Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)
Table 71. Roche Recent Development
Table 72. BioMerieux Company Details
Table 73. BioMerieux Business Overview
Table 74. BioMerieux Breast Cancer Diagnostic and Drug Technologies Product
Table 75. BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)
Table 76. BioMerieux Recent Development
Table 77. Becton Dickinson Company Details
Table 78. Becton Dickinson Business Overview
Table 79. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product
Table 80. Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)
Table 81. Becton Dickinson Recent Development
Table 82. GE Healthcare Company Details
Table 83. GE Healthcare Business Overview
Table 84. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product
Table 85. GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)
Table 86. GE Healthcare Recent Development
Table 87. Hologic Company Details
Table 88. Hologic Business Overview
Table 89. Hologic Breast Cancer Diagnostic and Drug Technologies Product
Table 90. Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)
Table 91. Hologic Recent Development
Table 92. Philips Company Details
Table 93. Philips Business Overview
Table 94. Philips Breast Cancer Diagnostic and Drug Technologies Product
Table 95. Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)
Table 96. Philips Recent Development
Table 97. PerkinElmer Company Details
Table 98. PerkinElmer Business Overview
Table 99. PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)
Table 100. PerkinElmer Recent Development
Table 101. Quest Diagnostics Company Details
Table 102. Quest Diagnostics Business Overview
Table 103. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product
Table 104. Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)
Table 105. Quest Diagnostics Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Type: 2020 VS 2027
Figure 2. Mammography Features
Figure 3. Biopsy Features
Figure 4. Other Features
Figure 5. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application: 2020 VS 2027
Figure 6. Ductal Carcinoma of Breast Case Studies
Figure 7. Invasive Ductal Carcinoma Case Studies
Figure 8. Lobular Carcinoma Case Studies
Figure 9. Triple Negative Breast Cancer Case Studies
Figure 10. Breast Cancer Diagnostic and Drug Technologies Report Years Considered
Figure 11. Global Breast Cancer Diagnostic and Drug Technologies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Breast Cancer Diagnostic and Drug Technologies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions: 2020 VS 2027
Figure 14. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2022-2027)
Figure 15. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Players in 2020
Figure 16. Global Top Breast Cancer Diagnostic and Drug Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Diagnostic and Drug Technologies as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Breast Cancer Diagnostic and Drug Technologies Revenue in 2020
Figure 18. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2016-2021)
Figure 19. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2022-2027)
Figure 20. North America Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2016-2027)
Figure 22. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2016-2027)
Figure 23. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2016-2027)
Figure 24. United States Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2016-2027)
Figure 28. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2016-2027)
Figure 29. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2016-2027)
Figure 30. Germany Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Share by Region (2016-2027)
Figure 40. China Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2016-2027)
Figure 48. Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2016-2027)
Figure 49. Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2016-2027)
Figure 50. Mexico Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2016-2027)
Figure 56. Turkey Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
Figure 61. BioMerieux Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
Figure 62. Becton Dickinson Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
Figure 63. GE Healthcare Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
Figure 64. Hologic Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
Figure 65. Philips Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
Figure 66. PerkinElmer Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
Figure 67. Quest Diagnostics Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---